Search bioRxiv⌕ Search

Biology subjects

Leibovitz, E.

Publications and source records attributed to Leibovitz, E..

2 recordsLinked to original sources

Investigating and Identifying Traditional Medicinal Plant Antioxidants: New Frontiers in Treating Age-related Maladies Associated with Oxidative Stress

Oxidative stress is regarded as an imbalance between pro-oxidant and antioxidant species that can result in cellular inflammation associated with illnesses including cancers and cognitive decline. This study investigated medicinal plant extracts for the presence of natural bioactive compounds to explore their antioxidant properties and potential therapeutic relevance in conditions related to oxidative stress. Extracts were created using water as a solvent and compared in triplicate to the positive control quercetin (1 mg/mL) in a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay; all extracts were serially diluted from 10 mg/mL creating 8 distinct concentrations. Absorbance readings were compared before and after DPPH administration. At the highest concentration, all extracts demonstrated absorbance change factors <10% relative to the DPPH negative control. This result clearly demonstrated antioxidant activity, as lesser relative absorbance changes indicated greater neutralization of violet DPPH into lighter diphenylpicryl hydrazine via free radical scavenging. Most notably, at lowest concentration, Averrhoa carambola and Psidium guajava represented the least relative absorbance changes at 14.17% and 10.39%, rivaling quercetins antioxidant activity- a statistically significant result (p < 0.05). LC-MS/MS analysis of these most potent extracts identified quercetin and kaempferol in Psidium guajava and vitexin-2-O-rhamnoside, isovitexin, saponarin, and an additional flavonoid glycoside in Averrhoa carambola. Such compounds may offer potential pharmacological effects, for example, vitexin-2-O-rhamnoside and isovitexin have demonstrated anticancer, antidiabetic, neuroprotective, and cardioprotective properties in part through oxidative stress reduction. Future research should corroborate compound effects in human cell culture models, as prior studies are often limited to non-human tissues. INTRODUCTIONA medicinal plant is a plant that "contains substances that can be used for therapeutic purposes or which are precursors for the synthesis of useful drugs."1 Medicinal plants contain different classes of potentially bioactive compounds, including, but not limited to peptides, alkaloids, phenylpropanoids, polyketides, and terpenoids.2 Such compounds have alleged and in certain cases documented anticancer, anti-inflammatory, antioxidant, antibacterial, antipyretic, vasodilatory, stimulant, and/or more properties that have been historically used in traditional medicine.1,3 Evidence suggests that medicinal plants have been used for at least 60,000 years in places including what would be modern-day Iraq.4 Medicinal plants are still used all around the world today; Dr. Tedros Adhanom Ghebreyesus of the WHO says "For many millions of people around the world, traditional medicine is the first port of call to treat many diseases."5 In addition, the prevalence of medicinal plants is evident in developed countries too, with the medicinal plant trade between India and China accounting for two to five billion dollars annually.1 However, many of these traditional treatments receive significant scrutiny from modern medicine and societys decreasing reliance on plant-derived drugs. While such scrutiny proves accurate in many cases, several traditional medicinal plants have been shown to offer bioactive compounds that are used as a standard medical practice. This includes morphine, "a natural alkaloid that is derived from resin extracts from the seeds of the opium poppy,"3 which is utilized in clinical settings for its profound analgesic effects,3 and quinine, an antimalarial drug derived from Cinchona officinalis bark.6 The current research project presented herein will serve to test traditional medicinal plant compounds to determine if their claims of relevance can be substantiated and to explore their potential effects on biological organisms, specifically regarding their antioxidant properties and ability to eliminate free radicals. Free radicals are unstable molecular species with unpaired electrons,7 and can contribute to oxidative stress in organisms. Oxidative stress "is considered as an imbalance between pro- and antioxidant species, which results in molecular and cellular damage."8 Examples of known antioxidants include the polyphenol quercetin, which is often used as a positive control for its relative strength in reducing free radicals.9 Demonstrated efficacy of these medicinal plants could provide potential preventative therapies for age-related illnesses and other maladies associated with oxidative stress, including cancers and cognitive decline.8,9 RESEARCH QUESTIONS AND PURPOSEDo the traditional medicinal plants under investigation contain bioactive compounds with antioxidant properties capable of neutralizing free radicals in a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay? How does the efficacy of the plant extracts compare to the positive control, quercetin, and the associated samples in terms of antioxidant activity as measured by the DPPH assay? Do the extract compounds identified via LC-MS/MS analysis offer potential therapeutic relevance in modern medicine? With our research, we aimed to identify bioactive compounds within medicinal plants, determine if such medicinal plants and their bioactive compounds have applications in modern medical treatments, and ensure medicinal plants are being used safely and accurately under the support of sound scientific evidence.

biochemistry↗

Screening the PRISM library against Staphylococcus aureus reveals a sesquiterpene lactone from Liriodendron tulipifera with inhibitory activity

Infections caused by the bacterium Staphylococcus aureus continue to pose threats to human health and put a financial burden on the healthcare system. The overuse of antibiotics has contributed to mutations leading to the emergence of methicillin-resistant Staphylococcus aureus, and there is a critical need for the discovery and development of new antibiotics to evade drug resistant bacteria. Medicinal plants have shown promise as sources of new small molecule therapeutics with potential uses against pathogenic infections. The Principal Rhode Island Secondary Metabolite (PRISM) library is a botanical extract library generated from specimens in the URI Heber W. Youngken Jr. Medicinal Garden by upper-division undergraduate students. PRISM extracts were screened for activity against strains of methicillin-susceptible S. aureus (MSSA). An extract generated from the tulip tree (Liriodendron tulipifera) demonstrated growth inhibition against MSSA, and a bioassay-guided approach identified a sesquiterpene lactone, laurenobiolide, as the active constituent. Intriguingly, its isomers tulipinolide and epi-tulipinolide lacked potent activity against MSSA. Laurenobiolide also proved to be more potent against MSSA than the structurally similar sesquiterpene lactones constunolide and dehydrocostus lactone. Laurenobioloide was most abundant in the twig bark of the tulip tree, supporting the historical and cultural usage of twig bark in poultices and teas. ABSTRACT GRAPHIC O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=94 SRC="FIGDIR/small/494747v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@952221org.highwire.dtl.DTLVardef@f3a5daorg.highwire.dtl.DTLVardef@d91daorg.highwire.dtl.DTLVardef@e2a845_HPS_FORMAT_FIGEXP M_FIG C_FIG

microbiology↗